Skip to main content
. 2019 Apr 11;12(2):55. doi: 10.3390/ph12020055

Figure 15.

Figure 15

A comparison of O-, N-, S-, and C-glycosides as FimH antagonists for therapy in Crohn’s disease [116,117,119].